Annual Revenue
$6.00 B
+$622.40 M+11.56%
31 December 2023
Summary:
Edwards Lifesciences annual revenue is currently $6.00 billion, with the most recent change of +$622.40 million (+11.56%) on 31 December 2023. During the last 3 years, it has risen by +$1.62 billion (+36.90%). EW annual revenue is now at all-time high.EW Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$1.35 B
-$31.50 M-2.27%
30 September 2024
Summary:
Edwards Lifesciences quarterly revenue is currently $1.35 billion, with the most recent change of -$31.50 million (-2.27%) on 30 September 2024. Over the past year, it has increased by +$111.00 million (+8.93%). EW quarterly revenue is now -40.10% below its all-time high of $2.26 billion, reached on 31 December 2023.EW Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$6.60 B
+$111.00 M+1.71%
30 September 2024
Summary:
Edwards Lifesciences TTM revenue is currently $6.60 billion, with the most recent change of +$111.00 million (+1.71%) on 30 September 2024. Over the past year, it has increased by +$1.25 billion (+23.43%). EW TTM revenue is now at all-time high.EW TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.6% | +8.9% | +23.4% |
| 3 y3 years | +36.9% | +3.4% | +29.6% |
| 5 y5 years | +61.3% | +23.8% | +59.0% |
EW Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.9% | -40.1% | +8.9% | at high | +29.6% |
| 5 y | 5 years | at high | +61.3% | -40.1% | +46.4% | at high | +59.0% |
| alltime | all time | at high | +767.6% | -40.1% | +816.4% | at high | +2820.2% |
Edwards Lifesciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.35 B(-2.3%) | $6.60 B(+1.7%) |
| June 2024 | - | $1.39 B(-13.3%) | $6.49 B(+1.4%) |
| Mar 2024 | - | $1.60 B(-29.3%) | $6.40 B(+2.2%) |
| Dec 2023 | $6.00 B(+11.6%) | $2.26 B(+81.9%) | $6.26 B(+17.1%) |
| Sept 2023 | - | $1.24 B(-4.0%) | $5.35 B(-1.4%) |
| June 2023 | - | $1.30 B(-11.2%) | $5.42 B(-1.4%) |
| Mar 2023 | - | $1.46 B(+8.3%) | $5.50 B(+2.2%) |
| Dec 2022 | $5.38 B(+2.9%) | $1.35 B(+2.2%) | $5.38 B(+0.3%) |
| Sept 2022 | - | $1.32 B(-4.0%) | $5.36 B(+0.2%) |
| June 2022 | - | $1.37 B(+2.4%) | $5.36 B(-0.0%) |
| Mar 2022 | - | $1.34 B(+0.9%) | $5.36 B(+2.4%) |
| Dec 2021 | $5.23 B(+19.3%) | $1.33 B(+1.5%) | $5.23 B(+2.7%) |
| Sept 2021 | - | $1.31 B(-4.8%) | $5.09 B(+3.4%) |
| June 2021 | - | $1.38 B(+13.1%) | $4.93 B(+10.1%) |
| Mar 2021 | - | $1.22 B(+2.1%) | $4.47 B(+2.0%) |
| Dec 2020 | $4.39 B(+0.9%) | $1.19 B(+4.5%) | $4.39 B(+0.4%) |
| Sept 2020 | - | $1.14 B(+23.3%) | $4.37 B(+1.1%) |
| June 2020 | - | $925.00 M(-18.0%) | $4.32 B(-3.6%) |
| Mar 2020 | - | $1.13 B(-3.9%) | $4.48 B(+3.1%) |
| Dec 2019 | $4.35 B(+16.8%) | $1.17 B(+7.3%) | $4.35 B(+4.7%) |
| Sept 2019 | - | $1.09 B(+0.7%) | $4.15 B(+4.7%) |
| June 2019 | - | $1.09 B(+9.5%) | $3.96 B(+3.7%) |
| Mar 2019 | - | $993.00 M(+1.6%) | $3.82 B(+2.6%) |
| Dec 2018 | $3.72 B(+8.4%) | $977.70 M(+7.8%) | $3.72 B(+2.5%) |
| Sept 2018 | - | $906.60 M(-3.9%) | $3.63 B(+2.4%) |
| June 2018 | - | $943.70 M(+5.5%) | $3.55 B(+3.0%) |
| Mar 2018 | - | $894.80 M(+0.7%) | $3.45 B(+0.3%) |
| Dec 2017 | $3.44 B(+15.9%) | $888.50 M(+8.2%) | $3.44 B(+3.6%) |
| Sept 2017 | - | $821.50 M(-2.4%) | $3.31 B(+2.5%) |
| June 2017 | - | $841.80 M(-4.7%) | $3.23 B(+2.6%) |
| Mar 2017 | - | $883.50 M(+15.1%) | $3.15 B(+6.3%) |
| Dec 2016 | $2.96 B(+18.8%) | $767.70 M(+3.8%) | $2.96 B(+3.4%) |
| Sept 2016 | - | $739.40 M(-2.6%) | $2.87 B(+4.5%) |
| June 2016 | - | $759.30 M(+8.9%) | $2.74 B(+5.5%) |
| Mar 2016 | - | $697.30 M(+3.9%) | $2.60 B(+4.3%) |
| Dec 2015 | $2.49 B(+7.4%) | $671.10 M(+9.0%) | $2.49 B(+2.2%) |
| Sept 2015 | - | $615.50 M(-0.2%) | $2.44 B(+0.3%) |
| June 2015 | - | $616.80 M(+4.5%) | $2.43 B(+1.7%) |
| Mar 2015 | - | $590.30 M(-4.5%) | $2.39 B(+2.9%) |
| Dec 2014 | $2.32 B(+13.6%) | $618.00 M(+1.7%) | $2.32 B(+3.7%) |
| Sept 2014 | - | $607.40 M(+5.6%) | $2.24 B(+5.3%) |
| June 2014 | - | $575.10 M(+10.1%) | $2.13 B(+2.8%) |
| Mar 2014 | - | $522.40 M(-2.5%) | $2.07 B(+1.3%) |
| Dec 2013 | $2.05 B(+7.7%) | $536.00 M(+8.2%) | $2.05 B(+1.3%) |
| Sept 2013 | - | $495.60 M(-4.2%) | $2.02 B(+2.4%) |
| June 2013 | - | $517.20 M(+4.1%) | $1.97 B(+1.8%) |
| Mar 2013 | - | $496.70 M(-2.7%) | $1.94 B(+2.0%) |
| Dec 2012 | $1.90 B | $510.50 M(+14.0%) | $1.90 B(+4.4%) |
| Sept 2012 | - | $447.90 M(-7.1%) | $1.82 B(+2.0%) |
| June 2012 | - | $482.00 M(+5.0%) | $1.78 B(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $459.20 M(+6.7%) | $1.73 B(+3.3%) |
| Dec 2011 | $1.68 B(+16.0%) | $430.20 M(+4.2%) | $1.68 B(+2.3%) |
| Sept 2011 | - | $412.70 M(-4.3%) | $1.64 B(+4.0%) |
| June 2011 | - | $431.20 M(+6.6%) | $1.58 B(+4.4%) |
| Mar 2011 | - | $404.50 M(+3.1%) | $1.51 B(+4.4%) |
| Dec 2010 | $1.45 B(+9.5%) | $392.40 M(+12.5%) | $1.45 B(+3.3%) |
| Sept 2010 | - | $348.90 M(-4.5%) | $1.40 B(+1.7%) |
| June 2010 | - | $365.20 M(+7.3%) | $1.38 B(+2.2%) |
| Mar 2010 | - | $340.50 M(-1.8%) | $1.35 B(+2.0%) |
| Dec 2009 | $1.32 B(+6.8%) | $346.70 M(+6.4%) | $1.32 B(+2.9%) |
| Sept 2009 | - | $325.70 M(-2.9%) | $1.28 B(+1.8%) |
| June 2009 | - | $335.50 M(+7.0%) | $1.26 B(+0.6%) |
| Mar 2009 | - | $313.50 M(+1.2%) | $1.25 B(+1.3%) |
| Dec 2008 | $1.24 B(+13.4%) | $309.70 M(+2.0%) | $1.24 B(+1.4%) |
| Sept 2008 | - | $303.60 M(-7.3%) | $1.22 B(+3.6%) |
| June 2008 | - | $327.60 M(+10.4%) | $1.18 B(+4.9%) |
| Mar 2008 | - | $296.80 M(+1.3%) | $1.12 B(+3.0%) |
| Dec 2007 | $1.09 B(+5.2%) | $293.00 M(+12.1%) | $1.09 B(+2.6%) |
| Sept 2007 | - | $261.40 M(-4.1%) | $1.06 B(+1.3%) |
| June 2007 | - | $272.60 M(+3.2%) | $1.05 B(+0.5%) |
| Mar 2007 | - | $264.10 M(-0.6%) | $1.04 B(+0.7%) |
| Dec 2006 | $1.04 B(+3.9%) | $265.60 M(+7.4%) | $1.04 B(+1.6%) |
| Sept 2006 | - | $247.40 M(-7.4%) | $1.02 B(+0.6%) |
| June 2006 | - | $267.30 M(+4.0%) | $1.01 B(+0.9%) |
| Mar 2006 | - | $257.00 M(+2.9%) | $1.01 B(+0.8%) |
| Dec 2005 | $997.90 M(+7.1%) | $249.70 M(+3.7%) | $997.90 M(+1.3%) |
| Sept 2005 | - | $240.90 M(-6.7%) | $985.30 M(+1.7%) |
| June 2005 | - | $258.20 M(+3.7%) | $969.20 M(+2.5%) |
| Mar 2005 | - | $249.10 M(+5.1%) | $945.60 M(+1.5%) |
| Dec 2004 | $931.50 M(+8.3%) | $237.10 M(+5.5%) | $931.50 M(+1.4%) |
| Sept 2004 | - | $224.80 M(-4.2%) | $918.50 M(+2.1%) |
| June 2004 | - | $234.60 M(-0.2%) | $899.80 M(+1.9%) |
| Mar 2004 | - | $235.00 M(+4.9%) | $883.00 M(+2.6%) |
| Dec 2003 | $860.50 M(+22.2%) | $224.10 M(+8.7%) | $860.50 M(+2.5%) |
| Sept 2003 | - | $206.10 M(-5.4%) | $839.50 M(+5.0%) |
| June 2003 | - | $217.80 M(+2.5%) | $799.20 M(+6.0%) |
| Mar 2003 | - | $212.50 M(+4.6%) | $754.20 M(+7.1%) |
| Dec 2002 | $704.00 M(+1.7%) | $203.10 M(+22.5%) | $704.00 M(+6.5%) |
| Sept 2002 | - | $165.80 M(-4.1%) | $660.90 M(+2.8%) |
| June 2002 | - | $172.80 M(+6.5%) | $642.90 M(-3.0%) |
| Mar 2002 | - | $162.30 M(+1.4%) | $662.50 M(-4.3%) |
| Dec 2001 | $692.10 M(-13.9%) | $160.00 M(+8.3%) | $692.10 M(-7.5%) |
| Sept 2001 | - | $147.80 M(-23.2%) | $748.60 M(-4.8%) |
| June 2001 | - | $192.40 M(+0.3%) | $786.60 M(-1.6%) |
| Mar 2001 | - | $191.90 M(-11.4%) | $799.20 M(-4.1%) |
| Dec 2000 | $804.00 M(-11.2%) | $216.50 M(+16.5%) | $833.30 M(+35.1%) |
| Sept 2000 | - | $185.80 M(-9.4%) | $616.80 M(+43.1%) |
| June 2000 | - | $205.00 M(-9.3%) | $431.00 M(+90.7%) |
| Mar 2000 | - | $226.00 M | $226.00 M |
| Dec 1999 | $905.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual revenue?
- What is the all time high annual revenue for Edwards Lifesciences?
- What is Edwards Lifesciences annual revenue year-on-year change?
- What is Edwards Lifesciences quarterly revenue?
- What is the all time high quarterly revenue for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly revenue year-on-year change?
- What is Edwards Lifesciences TTM revenue?
- What is the all time high TTM revenue for Edwards Lifesciences?
- What is Edwards Lifesciences TTM revenue year-on-year change?
What is Edwards Lifesciences annual revenue?
The current annual revenue of EW is $6.00 B
What is the all time high annual revenue for Edwards Lifesciences?
Edwards Lifesciences all-time high annual revenue is $6.00 B
What is Edwards Lifesciences annual revenue year-on-year change?
Over the past year, EW annual revenue has changed by +$622.40 M (+11.56%)
What is Edwards Lifesciences quarterly revenue?
The current quarterly revenue of EW is $1.35 B
What is the all time high quarterly revenue for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly revenue is $2.26 B
What is Edwards Lifesciences quarterly revenue year-on-year change?
Over the past year, EW quarterly revenue has changed by +$111.00 M (+8.93%)
What is Edwards Lifesciences TTM revenue?
The current TTM revenue of EW is $6.60 B
What is the all time high TTM revenue for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM revenue is $6.60 B
What is Edwards Lifesciences TTM revenue year-on-year change?
Over the past year, EW TTM revenue has changed by +$1.25 B (+23.43%)